Page 114 - Mercy MOR All Regions_FinalwVideo
P. 114

Key Performance Indicators  Metric                           $1,376  Springfield                               2.0%  % Variance 14.0%  $24,669,484
                                 Prior
  Budget
            Variance
 Actual
              ($262,924)
   $3,742,550
                                  $3,902,246
                          -7.0%
 Supply Expense
 $4,005,474
 Net Patient Revenue
                          -6.0%
 $24,545,720
             ($1,574,915)
  $26,120,635
                                    15.8%
 16.3%
      14.3%
 Supply Expense % Net Patient Revenue
 Supply Expense per EIPA
     $1,396
                                    $1,425
                           1.4%
                 $20
      1,397
                 128

 1,525
 Total Admissions
                                    1,413
                           9.2%
     15,847
 17,071
                           7.7%

 Total Patient Days
                                    16,320
                1,224
      2,682
                                    2,738
 2,910
 Total EIPAs
                           8.5%
                 228

 IP Surgeries
                          15.5%
                                     192
                 27
       174
 201

 OP Surgeries
 306

 Total Surgeries
       326
                          -6.1%
                 (20)
                                     364
                 (40)
                          -26.3%
       152

 Outpatient Cath Lab Procedures                               105                              153                               (48)  -31.4%                              172
 112
                                      96
 Site Performance Summary
 Springfield is over budget by $231K (6.2%). Primary contributing factors are: admissions up 9.2% and LOS up 9%; increased CRM
 Volume in Surgery and the Cath lab accounted for $124K; drug spend associated with the Flu and Respiratory increased volume ($47K),
 and lab increased spend on flu kits and Filmary (rapid respiratory and disease test). Total Supply cost associated with the flu volume
 was an increase of $94K (Lab + $63K, IV + $15K, med/surg +$11K, EVS + $5K) versus prior year. Lower Cath Lab volume attributed to
 the two highest volume Cardiologist being out at least a week each (Dr. Ahkter & Dr. Ashraf). While OR volume overall was down 6.1%
 there Net Revenue was over budget by 7.1%
 Key Challenges
       Favorable to budget by $45K
 Med/Surg   Cath Lab under budget 27% $59K attributed to volume below budget, the two highest volume
 Springfield Leader's Summary
 Cardiologist (Dr. Ahkter [out 10 days], Dr. Ashraf )were each out for at least a week each.
 OR under budget by 12%, $24K due to lower surgical volume -6%
     Drugs over budget by $135K (13.5%)
 Rx  Tamiflu accounted for $9K, $25K in spend for COPD
 $19K for Rituxamab which was not purchased in 2017 and an increase of $6K for stroke patient
             drugs
 Cath Lab implants were over budget by $155K. $88K in the Cath Lab for CRM and $36K in the OR
 over budget for CRM. We implanted 3 additional pacers, 4 AICD and 4 BIV AICD.
 Implants  Implant other over budget $77K. Two additional AAA performed in the Cath Lab accounted for
 $33K, and additional grafts performed in the Wound Clinics which is off set by revenue.
 Lab over budget by $55K attributed to the flu and respiratory test supplies ($63K)
 IV sets over by $23K due to flu $15K and B Braun IV catheters the were med surg supplies
            before.
 Other Expenses
 Minor Equipment medical is over $27K, due to DME purchased of Cpap devices and ventilators.
 These are rented to patients who then own them after a set period of time. Expenses hit when
 purchased with revenue to follow over a 13 month period.
 Actions Taken/Planned:
 Met with COO, CFO and OR director and have put in place a process that will not allow a case to
 be scheduled with high implant cost with out the director's and COO's approval.
 Reviewed payment for Reveal LINQ. And reimbursement is good. There are a few inpatients and
 I am working to verify the payment covers all charges.
 Met with director of the wound clinics to verify that reimbursement is there for the graft cases.
 There are a few that did not meet the criteria, but were approved based upon patient needs
           and payer.
   109   110   111   112   113   114   115   116   117   118   119